CORRECTION May 9, 2016: This article originally stated that the appeals court ruled against Medtronic. A federal appeals court today upheld a U.S. Patent & Trademark Office decision invalidating a stent patent licensed to Endotach, a subsidiary of patent troll Acacia Research, in its patent battle with Medtronic (NYSE:MDT). Endotach sued Medtronic in 2012, alleging that the medtech giant infringed a […]
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor’s widow, according to court documents.